Target intelligence / Profile preview

cyclin G1 pseudogene 1 (CCNG1P1)

Target: CCNG1P1
Molecular classification: Other (pseudogene)

Overview

Cyclin G1 pseudogene 1 (CCNG1P1) is a presumed pseudogene derived from the cyclin G1 (CCNG1) locus. Pseudogenes typically arise from gene duplications or retrotranspositions and do not encode functional proteins. There is no evidence of transcriptional activity, protein expression, or biomedical significance for CCNG1P1. In contrast, the canonical cyclin G1 (CCNG1) gene is a proto-oncogene involved in cell cycle regulation and cancer, but the pseudogene itself is not recognized as a functional entity or therapeutic target in the scientific literature or major gene databases.

Other names: Cyclin G1 pseudogene 1CCNG1P1

Beyond the preview

Go deeper on cyclin G1 pseudogene 1 (CCNG1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on cyclin G1 pseudogene 1 (CCNG1P1).

Explore the full profile